Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road Database
dpa

HOME > dpa

Financing of the German biotech sector collapses after coronavirus boom

January 19, 2023


Abstract : Following a boom during the coronavirus pandemic, the German biotech industry is again experiencing more difficult times.

CAPTION: Financing of the German biotech sector collapses after coronavirus boom. (picture alliance/dpa/Sebastian Gollnow)

Following a boom during the coronavirus pandemic, the German biotech industry is again experiencing more difficult times. After two years of record financing, less money flowed into companies in the sector in 2022, while the sentiment in the industry has darkened. This was announced by the industry association BIO Deutschland in Berlin. In the latest member survey, only 26 percent expected their business situation to improve, about half of the 2021 figure. "In addition to war, the energy crisis, and inflation, a shortage of skilled workers and a lack of financing options are slowing down our companies," said Oliver Schacht, CEO of BIO Deutschland.

Last year, he said, biotech companies raised about 920 million euros in equity via venture capitalists, IPOs, and capital increases on the stock market. That was less than a third of the record set in the first year of the pandemic, 2020, he said. "In terms of financing, the industry has fallen to pre-pandemic levels," Schacht said. With tech company stocks plummeting, it has also become harder for companies to get money from investors, he said.

During the pandemic, the biotech industry had boomed with beacons such as Mainz-based vaccine maker BioNTech. In 2020, the industry, which employs nearly 45,000 people in Germany, raised about 3.1 billion euros, and in 2021, about 2.4 billion euros.

Biotech companies experiment with complex active ingredients and therapies, and also develop technologies for the chemicals industry and agriculture. This is expensive and takes a long time, which is why biotech companies rely on a lot of money from investors, most of whom are based in the United States. Companies like BioNTech were drawn to the US technology exchange Nasdaq to go public.

Notice: No person, organization and/or company shall disseminate or broadcast the above article on Xinhua Silk Road website without prior permission by Xinhua Silk Road.

Scan the QR code and push it to your mobile phone

Keyword: biotech

Reading:

Moderna to negotiate with Beijing to supply COVID-19 vaccines

China promotes booster shots with variety of vaccine choices

Chinese delegations rush to fortify business ties in Europe

Lao, Chinese firms cooperate to boost cattle production for export to China

Chinese company Bloomage Biotech forges partnership with Japanese firms on regenerative medicine

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial